InventisBio (SH:688382) Xin Lang Cai Jing·2026-01-22 05:32Group 1 - Yifang Biotechnology's stock price fell by 5.01% on January 22, closing at 26.15 CNY per share, with a trading volume of 266 million CNY and a turnover rate of 2.38%, resulting in a total market capitalization of 15.124 billion CNY [1] - The stock has experienced a continuous decline over three days, with a cumulative drop of 8.66% during this period [1] - Yifang Biotechnology, established on January 11, 2013, and listed on July 25, 2022, focuses on the research, production, and sales of innovative drugs, with its main revenue derived entirely from technology licensing and cooperation [1] Group 2 - Tianzhi Fund holds a significant position in Yifang Biotechnology through its Tianzhi New Consumption Mixed Fund (350008), which has maintained a holding of 22,800 shares, accounting for 4.49% of the fund's net value, ranking as the ninth largest holding [2] - The fund has incurred a floating loss of approximately 31,400 CNY today, with a total floating loss of 59,400 CNY during the three-day decline [2] - Tianzhi New Consumption Mixed Fund was established on August 4, 2011, with a current scale of 19.07 million CNY, achieving a year-to-date return of 11.21% and a one-year return of 8.1% [2]